Dr. Harold Bays, Medical Director and President of the Louisville Metabolic and Atherosclerosis Research Center as well as Your Body Goal in Louisville, KY., and Chief Science Officer of Obesity Medicine Association shares his insight on obesity pharmacotherapy, cardiometabolic consequences of obesity as well as how the COVID-19 pandemic impacts obesity management.

Since the month of May is celebrated as Asian Pacific Heritage Month, in this podcast, we had an opportunity to talk with Dr. Leslie Cho, Professor of Medicine and Head of Preventive Cardiology and Rehabilitation at the Cleveland Clinic, Ohio, about the prevalence and management of statin intolerance particularly in individuals of East Asian descent.

In this podcast, CMHC Chair Robert Eckel, MD, co-president of the American Diabetes Association and Professor of Medicine at University of Colorado in Aurora, discusses the connections between obesity and COVID-19, as well as some updates on diabetes therapy in patients with diabetes and COVID-19.   Recorded April 27, 2020.

In this podcast, CMHC Chair Christie Ballantyne, MD, Professor of Medicine at Baylor College of Medicine, discusses the role of troponins and statins in COVID-19, and how has the pandemic impacted his practice.

In this podcast, Dr. Clyde Yancy, Professor of Medicine at Northwestern, discusses the connections between CVD and COVID-19, including cardiac injury, RAASi therapy, and more.

Listen to CMHC's Senior Planning Committee Member, Dr. Keith C. Ferdinand, Professor of Medicine at the Tulane University School of Medicine in New Orleans, LA, discuss whether ACEis and ARBs should be withdrawn in patients with COVID-19.

In this podcast, CMHC chair Dr. Anne Peters, Professor of Medicine and Director of Clinical Diabetes Programs at the University of Southern California in LA, discusses the impact of COVID-19 in patients with diabetes.